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Background: On CT coronary angiography (CTA), plaque in the absence of significant stenosis is frequently observed. However, the prognostic 
implications of this observation remain largely unknown. The purpose of the study was to evaluate whether cardiovascular risk in patients with non-
obstructive plaque changes over time as compared to patients with completely normal coronary arteries.
Methods: Cardiovascular event rates were compared between patients with normal coronary arteries (n=463) and patients with non-obstructive 
plaque (n=436) on CTA at 2- and 4-years follow-up.
Results: During the first 2-year follow-up, event-free survival rates of patients with non-obstructive plaque were similar to patients with normal 
coronary arteries (97% vs. 97.8%, p=0.524, Figure). However, after this initial period event rates started to diverge, resulting in a significantly lower 
event-free survival rate at 4-year follow-up in patients with non-obstructive plaque (94.3%) than in patients with normal coronary arteries (97.8%, 
p=0.039, Figure).
Conclusion: In patients with non-obstructive plaque, cardiovascular risk may change over time. Despite initial 
low risk comparable to patients with normal coronary arteries, an acceleration of risk occurs after 2 years.
